⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL47241 | 1.00 | — | — | |
| SCHEMBL17203543 | 1.00 | — | — | |
| SCHEMBL9431600 | 1.00 | — | — | |
| SCHEMBL427062 | 1.00 | — | — | |
| Bromide SCHEMBL19834621 | 0.97 | CHRNA7 (0.94) | — | |
| Hydrochloric Acid SCHEMBL348634 | 0.97 | CHRNA7 (0.94) | — | |
| Hydrochloric Acid SCHEMBL260467 | 0.97 | CHRNA7 (0.94) | — | |
| Hydrochloric Acid SCHEMBL2183739 | 0.97 | CHRNA7 (0.94) | — | |
| Hydrochloric Acid SCHEMBL492194 | 0.97 | CHRNA7 (0.94) | — | |
| Bromide SCHEMBL7114503 | 0.97 | CHRNA7 (0.94) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1633 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250101015-A1 | HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF | IOMX THERAPEUTICS AG (DE) | 2025-03-27 | — | — | US | claimed |
| EP-3481396-B1 | THERAPY OF BACTERIAL INFECTIONS. | SELECTIMMUNE PHARMA AB (SE) | 2023-05-31 | — | — | EP | claimed |
| EP-3976594-A1 | A THERAPEUTIC APPROACH FOR TREATING NON-INFECTIOUS OCULAR IMMUNOINFLAMMATORY DISORDERS | The Schepens Eye Research Institute, Inc. (US) | 2022-04-06 | — | — | EP | claimed |
| US-20210387982-A1 | HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF | IOMX THERAPEUTICS AG (DE) | 2021-12-16 | — | — | US | claimed |
| CN-107531689-B | Acid addition salts of 3-aminoquinuclidine without deliquescence | 有机合成药品工业株式会社 | 2021-04-13 | — | — | CN | claimed |
| CN-107203095-B | White alkali-soluble photosensitive composition and preparation method and application thereof | 江苏广信感光新材料股份有限公司 | 2020-08-18 | — | — | CN | claimed |
| CN-107329368-B | Alkali-soluble photosensitive composition, and preparation method and application thereof | 江苏广信感光新材料股份有限公司 | 2020-08-14 | — | — | CN | claimed |
| EP-3279199-B1 | NON-DELIQUESCENT ACID ADDITION SALT OF 3-AMINOQUINUCLIDINE | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2020-06-03 | — | — | EP | claimed |
| US-20180118736-A1 | NON-DELIQUESCENT ACID ADDITION SALT OF 3-AMINOQUINUCLIDINE | YUKI GOSEI KOGYO CO. LTD. (JP) | 2018-05-03 | — | — | US | claimed |
| EP-3279199-A1 | NON-DELIQUESCENT ACID ADDITION SALT OF 3-AMINOQUINUCLIDINE | YUKI GOSEI KOGYO CO., LTD. (JP) | 2018-02-07 | — | — | EP | claimed |
| WO-1991004253-A1 | PREPARATION OF S-(-)- AND R-(+)-N-(QUINUCLIDINYL-3)-AMIDE | CHIRON LABORATORIES A.S (NO) | 1991-04-04 | — | — | WO | claimed |
| US-4870181-A | AMIDATION OF 3-AMINOQUINUCLIDINE SALT | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-09-26 | — | — | US | claimed |
| EP-0311724-A1 | Anxiolytic-R-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides | SYNTHELABO (FR) | 1989-04-19 | — | — | EP | claimed |
| US-4818748-A | HYPOTENSIVE AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1989-04-04 | — | — | US | claimed |
| EP-0099789-B1 | 3-AMINOQUINUCLIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS THERAPEUTICAL AGENTS | DELALANDE S.A. (FR) | 1987-07-29 | — | — | EP | claimed |
| US-4657911-A | 3-amino quinuclidine derivatives and the application thereof as accelerators of gastro-intestinal motor function | DELALANDE S.A. (FR) | 1987-04-14 | — | — | US | claimed |
| EP-0190915-A2 | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides | SYNTHELABO (FR) | 1986-08-13 | — | — | EP | claimed |
| US-4596804-A | ANTIALLERGENS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1986-06-24 | — | — | US | claimed |
| EP-0158532-A2 | Use of 4-amino-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxybenzamide for the manufacture of a medicament having anti-emetic activity. | SYNTHELABO (FR) | 1985-10-16 | — | — | EP | claimed |
| EP-0130555-A2 | Dibenz (b,e) oxepin derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-01-09 | — | — | EP | claimed |